# Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

> **NCT05755269** · — · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 19 (actual)

## Conditions studied

- Breast Atypical Ductal Hyperplasia
- Breast Atypical Lobular Hyperplasia
- Breast Carcinoma
- Breast Lobular Carcinoma In Situ

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Genotyping
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT05755269
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-14
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755269, "Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05755269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*